G
Gwenael Ferron
Researcher at French Institute of Health and Medical Research
Publications - 213
Citations - 3873
Gwenael Ferron is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 29, co-authored 170 publications receiving 3171 citations. Previous affiliations of Gwenael Ferron include DuPont & University of Toulouse.
Papers
More filters
Journal ArticleDOI
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias,Jérémie H. Lefevre,Julie Chevalier,Antoine Brouquet,Frédéric Marchal,Jean-Marc Classe,Gwenael Ferron,Jean-Marc Guilloit,Pierre Meeus,Diane Goéré,Julia Bonastre +10 more
TL;DR: Patients with isolated, resectable PC achieve a median survival of 24 months with modern chemotherapies, but only surgical cytoreduction plus HIPEC is able to prolong median survival to roughly 63 months, with a 5-year survival rate of 51%.
Journal ArticleDOI
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients.
Naoual Bakrin,J.M. Bereder,Evelyne Decullier,Jean-Marc Classe,Simon Msika,Gérard Lorimier,Karine Abboud,Pierre Meeus,Gwenael Ferron,François Quenet,Frédéric Marchal,Sebastien Gouy,Philippe Morice,Christophe Pomel,Marc Pocard,Frédéric Guyon,Jack Porcheron,Olivier Glehen +17 more
TL;DR: For advanced and recurrent EOC, curative therapeutic approach combining optimal CRS and HIPEC should be considered as it may achieve long-term survival in patients with a severe prognosis disease, even in patientsWith chemoresistant disease.
Journal ArticleDOI
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20.
Andreas duBois,Ignace Vergote,Gwenael Ferron,Alexander Reuss,Werner Meier,Stefano Greggi,Pernille Tine Jensen,Frédéric Selle,Frédéric Guyon,C Pome,F Lecru,Rongyu Zang,Elisabeth Åvall-Lundqvist,Jae Weon Kim,Jordi Ponce,F. Raspagliesi,Sadaf Ghaem-Maghami,R Reinthaller,Philipp Harter,Jalid Sehouli +19 more
TL;DR: Results of the predetermined interim analysis show that complete resection was achieved in 67% of pts; 87% and 88% received a platinum-containing 2nd-line therapy.
Journal ArticleDOI
Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients
TL;DR: Evidence is given on a large series that laparoscopic lymph node dissection is safe and may be considered as the gold standard of assessment of the status of regional lymph nodes in gynecologic malignancies.
Journal ArticleDOI
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Eric Leblanc,Hélène Gauthier,Denis Querleu,Gwenael Ferron,Slimane Zerdoud,P. Morice,Catherine Uzan,S. Lumbroso,Fabrice Lecuru,Anne-Sophie Bats,N. Ghazzar,Marie Bannier,G. Houvenaeghel,I. Brenot-Rossi,Fabrice Narducci +14 more
TL;DR: Laparoscopic staging surgery seems warranted in LACC patients with negative PET scan who are candidates for definitive concurrent chemoradiotherapy or exenteration on the basis of sensitivity, specificity, and positive and negative predictive values of PET/CT.